home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

A Structure Of Antidepressants' Binding Sites

  August, 10 2005 4:12
your information resource in human molecular genetics
Some of the body's most important signalling molecules - such as serotonin and dopamine - rely on transporters to successfully clear them out of the extracellular space in the brain. Transporters move these neurotransmitters across the cell membrane by capitalizing on differences in ionic gradients. Eric Gouaux and his colleagues have now captured the crystal structure of a bacterial sodium/chloride-dependent transporter, which moves leucine across membranes. The structure, detailed in a paper published online by Nature, is the first glimpse of this large class of neurotransmitter sodium symporters.

The newly described structure has revealed the binding sites for ions and leucine, together with the 'gates' that must be opened to allow access to these sites. Gouaux and his team note that dysfunction of sodium/chloride-dependent transporters in humans contributes to multiple disorders, including Parkinson's disease and epilepsy. One member of this family of transporters, which moves serotonin, is currently targeted by fluoxetine (Prozac). Knowing the binding sites of these synaptic players will probably help experts to design better drug treatments for depression and neurodegenerative disorders.

Author contact

Eric J. E. Gouaux
Columbia University, New York, NY, USA.
E-mail: jeg52@columbia.edu

Abstract available online.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.